Page last updated: 2024-10-16

carbon monoxide and Pulmonary Arterial Hypertension

carbon monoxide has been researched along with Pulmonary Arterial Hypertension in 2 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Sugiyama, Y1
Matsubara, H1
Shimokawahara, H1
Ogawa, A1
Santaniello, A1
Casella, R1
Vicenzi, M1
Rota, I1
Montanelli, G1
De Santis, M1
Bellocchi, C1
Lombardi, F1
Beretta, L1

Other Studies

2 other studies available for carbon monoxide and Pulmonary Arterial Hypertension

ArticleYear
Outcome of mean pulmonary arterial pressure-based intensive treatment for patients with pulmonary arterial hypertension.
    Journal of cardiology, 2022, Volume: 80, Issue:5

    Topics: Arterial Pressure; Carbon Monoxide; Familial Primary Pulmonary Hypertension; Hemodynamics; Humans; H

2022
Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
    Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7

    Topics: Aged; Algorithms; Breath Tests; Carbon Monoxide; Cardiac Catheterization; Echocardiography, Doppler;

2020